Vision Medicals (广州微远基因科技有限公司, also known as Guangzhou Weiyuan Gene Technology) is a gene technology and precision medicine company. Its proprietary pathogenic nucleic acid enrichment technology, combined with high-throughput screening and CRISPR, discovers trace amounts of pathogens. The company develops a pathogen metagenomics platform and a pathogen rapid diagnosis platform.